Structure and function of the blood-brain barrier.
By N. Abbott, A. Patabendige, D. Dolman, Siti R. Yusof, D. Begley. Neurobiology of Disease, 2010
4,736 citations recorded by the source corpus.
Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment. Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier. The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange. The structure and function of the BBB is summarised, the physical barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms. The roles of associated cells are outlined, especially the endfeet of astrocytic glial cells, and pericytes and microglia. The embryonic development of the BBB, and changes in pathology are described. The BBB is subject to short and long-term regulation, which may be disturbed in pathology. Any programme for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.
Subfields: Cell Biology, Neurology, Oncology
View Paper: https://www.semanticscholar.org/paper/9b9dabba093c689a7a7ce9d60155a6b543ea5686
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Neurology
- Behnam Noorani
- Cynthia Hajal
- Amanda F. Levy
- Mao Ye
- Peter C. Searson
- M. Campisi
- I. Galea
- Jeffrey D. Rothstein
In Oncology
- Behnam Noorani
- Amanda F. Levy
- Mao Ye
- Peter C. Searson
- I. Galea
- Jeffrey D. Rothstein
- L. Cucullo
- Hossam Kadry
Citations in the corpus
- A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity (2020, background): “During embryonic angiogenesis, the differentiation of the endothelium into a functioning barrier layer begins and is maintained during adulthood by a close inductive association with other cell types within the NVU, as we mentioned early [2].”
- The blood-brain barrier in Alzheimer's disease (2017, neutral): “1) (Iadecola, 2004; Hawkins and Davis, 2005; Zlokovic, 2005; Abbott et al., 2010).”
- A new look at cerebrospinal fluid circulation (2014, background): “Recent research has unveiled that the ‘barrier’ function of the BBB is in fact the result of highly regulated and complex cellular and molecular transport processes, which allow for the transport of water, solutes, larger molecules and even cells (reviewed by [108-110]).”
- 3D Self-Organized Microvascular Model of the Human Blood-Brain Barrier with Endothelial Cells, Pericytes and Astrocytes (2018, background): “The blood-brain barrier (BBB) and blood-spinal cord barrier help maintain brain homeostasis [1] by regulating the transport of necessary nutrients, ions, and hormones, while preventing the entry of neurotoxins or pathogens into the brain owing to a complex membrane transport mechanism [2].”
- Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development (2021, background): “Thus the ability of a drug to penetrate the barrier to deliver to the site of action forms a crucial challenge in development of drugs for central nervous system (Abbott et al. 2010).”
- The blood-brain barrier: an engineering perspective (2013, background): “Finally, the entry of toxins and pathogens, such as bacteria and viruses circulating in the blood, can lead to neuron cell death and hence must also be prevented (Begley and Brightman, 2003; Hawkins and Davis, 2005; Abbott et al., 2010).”
- Brain metabolism in health, aging, and neurodegeneration (2017, neutral): “This article is a U.S. Government work and is in the public domain in the USA The EMBO Journal Vol 36 | No 11 | 2017 monocarboxylic acids, nucleotides, fatty acids, and organic anions and cations (Abbott et al, 2010).”
- Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation (2012, neutral): “The BBB maintains the homeostasis of the central nervous system (CNS) by (i) strictly limiting the passive diffusion of polar substances from the blood to the brain, (ii) mediating the transport of nutrients to the brain parenchyma as well as the efflux from the brain of toxic metabolites and xenobi”
- Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. (2016, background): “The transcellular pathway occurs in most cases with passive diffusion of lipophilic molecules, which takes place through specific receptors to transport molecules such as carbon dioxide [6].”